Clinical Trial Update: A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of combining guselkumab with golimumab in moderately to severely active ulcerative colitis has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Golimumab (golimumab)
• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2023-12-12